Epanutin 100 mg Capsules
PDF Leaflet Revision Date: 06 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Control of generalized tonic-clonic and complex partial seizures.
Dosage (summary)
Adults: 300 mg daily, adjusted as needed; max 600 mg. Pediatric: 5 mg/kg/day, max 300 mg.
Onset of Action / Duration
Onset: 7-10 days for steady state.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy; teratogenic risk. Not recommended during breastfeeding.
Key Drug Interactions
- Nelfinavir
- Alcohol
- CYP450 inducers/inhibitors
Contraindications
- Hypersensitivity to phenytoin
- Porphyria
Common side effects
- Dizziness
- Nystagmus
- Gingival hyperplasia
- Nausea
Counselling Points
- Monitor serum levels regularly
- Avoid abrupt discontinuation
- Report any skin rashes immediately
Serious warnings
- Risk of status epilepticus if abruptly discontinued
- Suicidal ideation risk
- Anticonvulsant Hypersensitivity Syndrome
Important Disclaimer
The Epanutin 100 mg Capsules professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
